English

CORE LABORATORIES N V

EDGAR

CLB Quarterly report (10-Q) · filed 2023-04-27

122 filing records in this dataset, filed from 1996-05-14 to 2023-04-27. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

128 million USD

2023 Q1 · USD

Exact inputs and evidence

Revenue: 128356000 USD Source

Operating margin

5.05%

2023 Q1 · %

Exact inputs and evidence

Operating Income: 6481000 USD Source
Revenue: 128356000 USD Source

Operating cash flow

-3.17 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -3169000 USD Source

Free cash flow

-5.38 million USD

2023 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -3169000 USD Source
Capital Expenditure: 2208000 USD Source

Cash and cash equivalents: 16.3 million USD 2023-03-31 Source
Exact value

16285000 USD
Long-term debt including current maturities: 183 million USD 2023-03-31 Source
Exact value

183000000 USD
Shares outstanding: 46.6 million shares 2023-03-31 Source
Exact value

46634027 shares

Reported share-count change

0.76% · 350 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

46283677 shares · 2022-03-31· Source
46634027 shares · 2023-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

503 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Revenue: 120898000 USD · 2022-04-01 – 2022-06-30 Source
Revenue: 125966000 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 489735000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 362164000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 128356000 USD · 2023-01-01 – 2023-03-31 Source

Net income

23.7 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Net income: 7066000 USD · 2022-04-01 – 2022-06-30 Source
Net income: 7524000 USD · 2022-07-01 – 2022-09-30 Source
Net income: 19453000 USD · 2022-01-01 – 2022-12-31 Source
Net income: 12702000 USD · 2022-01-01 – 2022-09-30 Source
Net income: 2373000 USD · 2023-01-01 – 2023-03-31 Source

Operating cash flow

16.5 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Operating cash flow: 5895000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: 5290000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: 11745000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: 5895000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: 24956000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: 11745000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -3169000 USD · 2023-01-01 – 2023-03-31 Source

Capital expenditure

10.1 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Capital expenditure: 3197000 USD · 2022-04-01 – 2022-06-30 Source
Capital expenditure: 2702000 USD · 2022-07-01 – 2022-09-30 Source
Capital expenditure: 10216000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 8195000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 2208000 USD · 2023-01-01 – 2023-03-31 Source

Free cash flow

6.37 million USD

2022-04-01 – 2023-03-31

Exact inputs and evidence

Operating cash flow: 5895000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: 5290000 USD · 2022-01-01 – 2022-03-31 Source
Operating cash flow: 11745000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: 5895000 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: 24956000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: 11745000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -3169000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 3197000 USD · 2022-04-01 – 2022-06-30 Source
Capital expenditure: 2702000 USD · 2022-07-01 – 2022-09-30 Source
Capital expenditure: 10216000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 8195000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 2208000 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-04-27.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2022-12-31
Operating income: 7 of 11 periods available· newest 2022-12-31
Net income: 11 of 11 periods available· newest 2022-12-31
Operating cash flow: 11 of 11 periods available· newest 2022-12-31
Capital expenditure: 11 of 11 periods available· newest 2022-12-31
Total assets: 11 of 11 periods available· newest 2022-12-31
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2022-12-31
Current liabilities: 11 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2022-12-31
Long-term debt including current maturities: 11 of 11 periods available· newest 2022-12-31
Shares outstanding: 11 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+4.1%

Prior period

USD 470.25 million

2021-01-01 – 2021-12-31
Current period

USD 489.74 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

489735000 − 470252000 = 19483000 USD

470252000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
489735000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CORE LABORATORIES N V · 2022-12-31 CORE LABORATORIES N V (edgar:1000229) Year-over-year change in Revenue: 19483000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 489735000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5271932 Filing: 000095017023002412 Input fundies:Revenue: 470252000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5293314 Filing: 000095017023002412
The citation records this snapshot. The page link may show a newer release later.
Net income
-1.4%

Prior period

USD 19.73 million

2021-01-01 – 2021-12-31
Current period

USD 19.45 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

19453000 − 19727000 = -274000 USD

19727000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
19453000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CORE LABORATORIES N V · 2022-12-31 CORE LABORATORIES N V (edgar:1000229) Year-over-year change in Net income: -274000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 19453000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2228193 Filing: 000095017023002412 Input fundies:NetIncome: 19727000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2230335 Filing: 000095017023002412
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-31.8%

Prior period

USD 36.58 million

2021-01-01 – 2021-12-31
Current period

USD 24.96 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

24956000 − 36579000 = -11623000 USD

36579000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
24956000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CORE LABORATORIES N V · 2022-12-31 CORE LABORATORIES N V (edgar:1000229) Year-over-year change in Operating cash flow: -11623000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 24956000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2994513 Filing: 000095017023002412 Input fundies:OperatingCashFlow: 36579000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2996571 Filing: 000095017023002412
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-24.5%

Prior period

USD 13.54 million

2021-01-01 – 2021-12-31
Current period

USD 10.22 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

10216000 − 13539000 = -3323000 USD

13539000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
10216000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CORE LABORATORIES N V · 2022-12-31 CORE LABORATORIES N V (edgar:1000229) Year-over-year change in Capital expenditure: -3323000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 10216000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5052966 Filing: 000095017023002412 Input fundies:CapitalExpenditure: 13539000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5114241 Filing: 000095017023002412
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 489.74 million 100% of revenue
Operating costs Derived USD 448.21 million 92% of revenue
Operating income USD 41.52 million 8.5% of revenue
Tax, interest and other Derived USD 22.07 million 4.5% of revenue
Net income USD 19.45 million 4% of revenue

Cash

Operating cash flow USD 24.96 million 5.1% of revenue
Capital expenditure USD 10.22 million 2.1% of revenue
Free cash flow Derived USD 14.74 million 3% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2015 Not shown: operating income or net income is not reported.
2016 11%85%
2017 13%83%
2018 11%83%
2019 Net income was higher than operating income, so the split is not drawn.
2020 Operating loss: operating costs were 116% of revenue.
2021 90%
2022 92%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2013-01-01 – 2013-12-31	1073508000	Unavailable	Unavailable	Unavailable	242811000	262721000 Derived	Source 2013-01-01 – 2013-12-31: 1073508000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 242811000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: 298137000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 35416000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	1085222000	Unavailable	Unavailable	Unavailable	257485000	266863000 Derived	Source 2014-01-01 – 2014-12-31: 1085222000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 257485000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 303449000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 36586000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	797520000	Unavailable	Unavailable	Unavailable	114847000	196303000 Derived	Source 2015-01-01 – 2015-12-31: 797520000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 114847000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 219100000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 22797000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	590232000	502781000 Derived	87451000	23556000 Derived	63895000	120531000 Derived	Source 2016-01-01 – 2016-12-31: 590232000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 87451000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 63895000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 131887000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 11356000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	647819000	537851000 Derived	109968000	26843000 Derived	83125000	105496000 Derived	Source 2017-01-01 – 2017-12-31: 647819000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: 109968000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 83125000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 124271000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 18775000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	700846000	582224000 Derived	118622000	39096000 Derived	79526000	90086000 Derived	Source 2018-01-01 – 2018-12-31: 700846000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 118622000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 79526000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 111827000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 21741000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	668210000	571526000 Derived	96684000	-5299000 Derived	101983000	67258000 Derived	Source 2019-01-01 – 2019-12-31: 668210000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 96684000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 101983000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 89527000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 22269000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	487267000	564072000 Derived	-76805000	20832000 Derived	-97637000	45988000 Derived	Source 2020-01-01 – 2020-12-31: 487267000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -76805000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -97637000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 57868000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 11880000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	470252000	424990000 Derived	45262000	25535000 Derived	19727000	23040000 Derived	Source 2021-01-01 – 2021-12-31: 470252000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 45262000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 19727000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 36579000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 13539000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	489735000	448211000 Derived	41524000	22071000 Derived	19453000	14740000 Derived	Source 2022-01-01 – 2022-12-31: 489735000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 41524000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 19453000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 24956000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 10216000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 489.7M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Revenue	1073508000	Revenue: 1073508000 Open source
20142014-12-31	Revenue	1085222000	Revenue: 1085222000 Open source
20152015-12-31	Revenue	797520000	Revenue: 797520000 Open source
20162016-12-31	Revenue	590232000	Revenue: 590232000 Open source
20172017-12-31	Revenue	647819000	Revenue: 647819000 Open source
20182018-12-31	Revenue	700846000	Revenue: 700846000 Open source
20192019-12-31	Revenue	668210000	Revenue: 668210000 Open source
20202020-12-31	Revenue	487267000	Revenue: 487267000 Open source
20212021-12-31	Revenue	470252000	Revenue: 470252000 Open source
20222022-12-31	Revenue	489735000	Revenue: 489735000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

4.1% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Year over year	9.4%	Revenue: 1073508000 Open source Revenue: 981080000 Open source
20142014-12-31	Year over year	1.1%	Revenue: 1085222000 Open source Revenue: 1073508000 Open source
20152015-12-31	Year over year	-26.5%	Revenue: 797520000 Open source Revenue: 1085222000 Open source
20162016-12-31	Year over year	-26%	Revenue: 590232000 Open source Revenue: 797520000 Open source
20172017-12-31	Year over year	9.8%	Revenue: 647819000 Open source Revenue: 590232000 Open source
20182018-12-31	Year over year	8.2%	Revenue: 700846000 Open source Revenue: 647819000 Open source
20192019-12-31	Year over year	-4.7%	Revenue: 668210000 Open source Revenue: 700846000 Open source
20202020-12-31	Year over year	-27.1%	Revenue: 487267000 Open source Revenue: 668210000 Open source
20212021-12-31	Year over year	-3.5%	Revenue: 470252000 Open source Revenue: 487267000 Open source
20222022-12-31	Year over year	4.1%	Revenue: 489735000 Open source Revenue: 470252000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 8.5% 2022

Net margin 4% 2022

Free cash flow margin 3% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2013-12-31	Operating margin	Not reported	Revenue: 1073508000 Open source
2014-12-31	Operating margin	Not reported	Revenue: 1085222000 Open source
2015-12-31	Operating margin	Not reported	Revenue: 797520000 Open source
20162016-12-31	Operating margin	14.8%	Operating Income: 87451000 Open source Revenue: 590232000 Open source
20172017-12-31	Operating margin	17%	Operating Income: 109968000 Open source Revenue: 647819000 Open source
20182018-12-31	Operating margin	16.9%	Operating Income: 118622000 Open source Revenue: 700846000 Open source
20192019-12-31	Operating margin	14.5%	Operating Income: 96684000 Open source Revenue: 668210000 Open source
20202020-12-31	Operating margin	-15.8%	Operating Income: -76805000 Open source Revenue: 487267000 Open source
20212021-12-31	Operating margin	9.6%	Operating Income: 45262000 Open source Revenue: 470252000 Open source
20222022-12-31	Operating margin	8.5%	Operating Income: 41524000 Open source Revenue: 489735000 Open source
20132013-12-31	Net margin	22.6%	Net Income: 242811000 Open source Revenue: 1073508000 Open source
20142014-12-31	Net margin	23.7%	Net Income: 257485000 Open source Revenue: 1085222000 Open source
20152015-12-31	Net margin	14.4%	Net Income: 114847000 Open source Revenue: 797520000 Open source
20162016-12-31	Net margin	10.8%	Net Income: 63895000 Open source Revenue: 590232000 Open source
20172017-12-31	Net margin	12.8%	Net Income: 83125000 Open source Revenue: 647819000 Open source
20182018-12-31	Net margin	11.3%	Net Income: 79526000 Open source Revenue: 700846000 Open source
20192019-12-31	Net margin	15.3%	Net Income: 101983000 Open source Revenue: 668210000 Open source
20202020-12-31	Net margin	-20%	Net Income: -97637000 Open source Revenue: 487267000 Open source
20212021-12-31	Net margin	4.2%	Net Income: 19727000 Open source Revenue: 470252000 Open source
20222022-12-31	Net margin	4%	Net Income: 19453000 Open source Revenue: 489735000 Open source
20132013-12-31	Free cash flow margin	24.5%	Revenue: 1073508000 Open source Operating Cash Flow: 298137000 Open source Capital Expenditure: 35416000 Open source
20142014-12-31	Free cash flow margin	24.6%	Revenue: 1085222000 Open source Operating Cash Flow: 303449000 Open source Capital Expenditure: 36586000 Open source
20152015-12-31	Free cash flow margin	24.6%	Revenue: 797520000 Open source Operating Cash Flow: 219100000 Open source Capital Expenditure: 22797000 Open source
20162016-12-31	Free cash flow margin	20.4%	Revenue: 590232000 Open source Operating Cash Flow: 131887000 Open source Capital Expenditure: 11356000 Open source
20172017-12-31	Free cash flow margin	16.3%	Revenue: 647819000 Open source Operating Cash Flow: 124271000 Open source Capital Expenditure: 18775000 Open source
20182018-12-31	Free cash flow margin	12.9%	Revenue: 700846000 Open source Operating Cash Flow: 111827000 Open source Capital Expenditure: 21741000 Open source
20192019-12-31	Free cash flow margin	10.1%	Revenue: 668210000 Open source Operating Cash Flow: 89527000 Open source Capital Expenditure: 22269000 Open source
20202020-12-31	Free cash flow margin	9.4%	Revenue: 487267000 Open source Operating Cash Flow: 57868000 Open source Capital Expenditure: 11880000 Open source
20212021-12-31	Free cash flow margin	4.9%	Revenue: 470252000 Open source Operating Cash Flow: 36579000 Open source Capital Expenditure: 13539000 Open source
20222022-12-31	Free cash flow margin	3%	Revenue: 489735000 Open source Operating Cash Flow: 24956000 Open source Capital Expenditure: 10216000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 25M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Operating cash flow	298137000	Operating Cash Flow: 298137000 Open source
20142014-12-31	Operating cash flow	303449000	Operating Cash Flow: 303449000 Open source
20152015-12-31	Operating cash flow	219100000	Operating Cash Flow: 219100000 Open source
20162016-12-31	Operating cash flow	131887000	Operating Cash Flow: 131887000 Open source
20172017-12-31	Operating cash flow	124271000	Operating Cash Flow: 124271000 Open source
20182018-12-31	Operating cash flow	111827000	Operating Cash Flow: 111827000 Open source
20192019-12-31	Operating cash flow	89527000	Operating Cash Flow: 89527000 Open source
20202020-12-31	Operating cash flow	57868000	Operating Cash Flow: 57868000 Open source
20212021-12-31	Operating cash flow	36579000	Operating Cash Flow: 36579000 Open source
20222022-12-31	Operating cash flow	24956000	Operating Cash Flow: 24956000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 14.7M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Free cash flow	262721000	Operating Cash Flow: 298137000 Open source Capital Expenditure: 35416000 Open source
20142014-12-31	Free cash flow	266863000	Operating Cash Flow: 303449000 Open source Capital Expenditure: 36586000 Open source
20152015-12-31	Free cash flow	196303000	Operating Cash Flow: 219100000 Open source Capital Expenditure: 22797000 Open source
20162016-12-31	Free cash flow	120531000	Operating Cash Flow: 131887000 Open source Capital Expenditure: 11356000 Open source
20172017-12-31	Free cash flow	105496000	Operating Cash Flow: 124271000 Open source Capital Expenditure: 18775000 Open source
20182018-12-31	Free cash flow	90086000	Operating Cash Flow: 111827000 Open source Capital Expenditure: 21741000 Open source
20192019-12-31	Free cash flow	67258000	Operating Cash Flow: 89527000 Open source Capital Expenditure: 22269000 Open source
20202020-12-31	Free cash flow	45988000	Operating Cash Flow: 57868000 Open source Capital Expenditure: 11880000 Open source
20212021-12-31	Free cash flow	23040000	Operating Cash Flow: 36579000 Open source Capital Expenditure: 13539000 Open source
20222022-12-31	Free cash flow	14740000	Operating Cash Flow: 24956000 Open source Capital Expenditure: 10216000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2013-12-31	Liabilities / assets	Not reported	Total Assets: 659364000 Open source
2014-12-31	Liabilities / assets	Not reported	Total Assets: 673325000 Open source
2015-12-31	Liabilities / assets	Not reported	Total Assets: 625258000 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 573052000 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 584812000 Open source
2018-12-31	Liabilities / assets	Not reported	Total Assets: 648827000 Open source
2019-12-31	Liabilities / assets	Not reported	Total Assets: 774673000 Open source
2020-12-31	Liabilities / assets	Not reported	Total Assets: 568579000 Open source
2021-12-31	Liabilities / assets	Not reported	Total Assets: 580853000 Open source
2022-12-31	Liabilities / assets	Not reported	Total Assets: 578354000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.05× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Current assets / current liabilities	2.24×	Current Assets: 303868000 Open source Current Liabilities: 135775000 Open source
20142014-12-31	Current assets / current liabilities	2.29×	Current Assets: 301820000 Open source Current Liabilities: 131866000 Open source
20152015-12-31	Current assets / current liabilities	1.98×	Current Assets: 238547000 Open source Current Liabilities: 120758000 Open source
20162016-12-31	Current assets / current liabilities	1.79×	Current Assets: 186461000 Open source Current Liabilities: 104023000 Open source
20172017-12-31	Current assets / current liabilities	2.06×	Current Assets: 207427000 Open source Current Liabilities: 100576000 Open source
20182018-12-31	Current assets / current liabilities	2.25×	Current Assets: 230977000 Open source Current Liabilities: 102547000 Open source
20192019-12-31	Current assets / current liabilities	1.98×	Current Assets: 221237000 Open source Current Liabilities: 111594000 Open source
20202020-12-31	Current assets / current liabilities	1.85×	Current Assets: 165848000 Open source Current Liabilities: 89750000 Open source
20212021-12-31	Current assets / current liabilities	2.08×	Current Assets: 189055000 Open source Current Liabilities: 90782000 Open source
20222022-12-31	Current assets / current liabilities	2.05×	Current Assets: 211702000 Open source Current Liabilities: 103135000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	USD 242.81 million Exact value Exact value: 242811000 USD 2013-01-01 – 2013-12-31: 242811000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2013-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: 242811000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 242811000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022916000149/clb-20151231.xml#309151 Filing: 000100022916000149 The citation records this snapshot. The page link may show a newer release later.	USD 298.14 million Exact value Exact value: 298137000 USD 2013-01-01 – 2013-12-31: 298137000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2013-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 298137000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 298137000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022916000149/clb-20151231.xml#308515 Filing: 000100022916000149 The citation records this snapshot. The page link may show a newer release later.	USD 35.42 million Exact value Exact value: 35416000 USD 2013-01-01 – 2013-12-31: 35416000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2013-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 35416000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35416000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022916000149/clb-20151231.xml#342631 Filing: 000100022916000149 The citation records this snapshot. The page link may show a newer release later.	USD 262.72 million Calculation and evidence 298137000 − 35416000 USD Exact free cash flow: 262721000 USD 2013-01-01 – 2013-12-31: 298137000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 35416000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2013-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 262721000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 298137000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022916000149/clb-20151231.xml#308515 Filing: 000100022916000149 Input fundies:CapitalExpenditure: 35416000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022916000149/clb-20151231.xml#342631 Filing: 000100022916000149 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	USD 257.49 million Exact value Exact value: 257485000 USD 2014-01-01 – 2014-12-31: 257485000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2014-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: 257485000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 257485000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022917000025/clb-20161231.xml#320906 Filing: 000100022917000025 The citation records this snapshot. The page link may show a newer release later.	USD 303.45 million Exact value Exact value: 303449000 USD 2014-01-01 – 2014-12-31: 303449000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2014-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 303449000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 303449000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022917000025/clb-20161231.xml#320270 Filing: 000100022917000025 The citation records this snapshot. The page link may show a newer release later.	USD 36.59 million Exact value Exact value: 36586000 USD 2014-01-01 – 2014-12-31: 36586000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2014-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 36586000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36586000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022917000025/clb-20161231.xml#354006 Filing: 000100022917000025 The citation records this snapshot. The page link may show a newer release later.	USD 266.86 million Calculation and evidence 303449000 − 36586000 USD Exact free cash flow: 266863000 USD 2014-01-01 – 2014-12-31: 303449000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 36586000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2014-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 266863000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 303449000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022917000025/clb-20161231.xml#320270 Filing: 000100022917000025 Input fundies:CapitalExpenditure: 36586000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022917000025/clb-20161231.xml#354006 Filing: 000100022917000025 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	USD 114.85 million Exact value Exact value: 114847000 USD 2015-01-01 – 2015-12-31: 114847000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2015-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: 114847000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 114847000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022918000025/clb-20171231.xml#304478 Filing: 000100022918000025 The citation records this snapshot. The page link may show a newer release later.	USD 219.1 million Exact value Exact value: 219100000 USD 2015-01-01 – 2015-12-31: 219100000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2015-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 219100000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 219100000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022918000025/clb-20171231.xml#303842 Filing: 000100022918000025 The citation records this snapshot. The page link may show a newer release later.	USD 22.8 million Exact value Exact value: 22797000 USD 2015-01-01 – 2015-12-31: 22797000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2015-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 22797000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22797000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022918000025/clb-20171231.xml#335859 Filing: 000100022918000025 The citation records this snapshot. The page link may show a newer release later.	USD 196.3 million Calculation and evidence 219100000 − 22797000 USD Exact free cash flow: 196303000 USD 2015-01-01 – 2015-12-31: 219100000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 22797000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2015-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 196303000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 219100000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022918000025/clb-20171231.xml#303842 Filing: 000100022918000025 Input fundies:CapitalExpenditure: 22797000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022918000025/clb-20171231.xml#335859 Filing: 000100022918000025 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	USD 63.9 million Exact value Exact value: 63895000 USD 2016-01-01 – 2016-12-31: 63895000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2016-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: 63895000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 63895000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022919000021/clb-20181231.xml#387187 Filing: 000100022919000021 The citation records this snapshot. The page link may show a newer release later.	USD 131.89 million Exact value Exact value: 131887000 USD 2016-01-01 – 2016-12-31: 131887000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2016-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 131887000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 131887000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022919000021/clb-20181231.xml#386551 Filing: 000100022919000021 The citation records this snapshot. The page link may show a newer release later.	USD 11.36 million Exact value Exact value: 11356000 USD 2016-01-01 – 2016-12-31: 11356000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2016-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 11356000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11356000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022919000021/clb-20181231.xml#420503 Filing: 000100022919000021 The citation records this snapshot. The page link may show a newer release later.	USD 120.53 million Calculation and evidence 131887000 − 11356000 USD Exact free cash flow: 120531000 USD 2016-01-01 – 2016-12-31: 131887000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 11356000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2016-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 120531000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 131887000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022919000021/clb-20181231.xml#386551 Filing: 000100022919000021 Input fundies:CapitalExpenditure: 11356000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000100022919000021/clb-20181231.xml#420503 Filing: 000100022919000021 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	USD 83.13 million Exact value Exact value: 83125000 USD 2017-01-01 – 2017-12-31: 83125000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2017-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: 83125000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 83125000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459020004075/clb-10k_20191231.htm#1978102 Filing: 000156459020004075 The citation records this snapshot. The page link may show a newer release later.	USD 124.27 million Exact value Exact value: 124271000 USD 2017-01-01 – 2017-12-31: 124271000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2017-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 124271000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 124271000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459020004075/clb-10k_20191231.htm#2662922 Filing: 000156459020004075 The citation records this snapshot. The page link may show a newer release later.	USD 18.78 million Exact value Exact value: 18775000 USD 2017-01-01 – 2017-12-31: 18775000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2017-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 18775000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18775000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459020004075/clb-10k_20191231.htm#4584869 Filing: 000156459020004075 The citation records this snapshot. The page link may show a newer release later.	USD 105.5 million Calculation and evidence 124271000 − 18775000 USD Exact free cash flow: 105496000 USD 2017-01-01 – 2017-12-31: 124271000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 18775000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2017-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 105496000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 124271000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459020004075/clb-10k_20191231.htm#2662922 Filing: 000156459020004075 Input fundies:CapitalExpenditure: 18775000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459020004075/clb-10k_20191231.htm#4584869 Filing: 000156459020004075 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 79.53 million Exact value Exact value: 79526000 USD 2018-01-01 – 2018-12-31: 79526000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2018-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: 79526000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 79526000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459021004561/clb-10k_20201231.htm#2093473 Filing: 000156459021004561 The citation records this snapshot. The page link may show a newer release later.	USD 111.83 million Exact value Exact value: 111827000 USD 2018-01-01 – 2018-12-31: 111827000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2018-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 111827000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 111827000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459021004561/clb-10k_20201231.htm#2810608 Filing: 000156459021004561 The citation records this snapshot. The page link may show a newer release later.	USD 21.74 million Exact value Exact value: 21741000 USD 2018-01-01 – 2018-12-31: 21741000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2018-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 21741000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21741000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459021004561/clb-10k_20201231.htm#4788634 Filing: 000156459021004561 The citation records this snapshot. The page link may show a newer release later.	USD 90.09 million Calculation and evidence 111827000 − 21741000 USD Exact free cash flow: 90086000 USD 2018-01-01 – 2018-12-31: 111827000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 21741000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2018-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 90086000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 111827000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459021004561/clb-10k_20201231.htm#2810608 Filing: 000156459021004561 Input fundies:CapitalExpenditure: 21741000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000156459021004561/clb-10k_20201231.htm#4788634 Filing: 000156459021004561 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 101.98 million Exact value Exact value: 101983000 USD 2019-01-01 – 2019-12-31: 101983000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2019-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: 101983000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 101983000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017022001087/clb-20211231.htm#1877828 Filing: 000095017022001087 The citation records this snapshot. The page link may show a newer release later.	USD 89.53 million Exact value Exact value: 89527000 USD 2019-01-01 – 2019-12-31: 89527000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2019-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 89527000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 89527000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017022001087/clb-20211231.htm#2590878 Filing: 000095017022001087 The citation records this snapshot. The page link may show a newer release later.	USD 22.27 million Exact value Exact value: 22269000 USD 2019-01-01 – 2019-12-31: 22269000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2019-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 22269000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22269000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017022001087/clb-20211231.htm#4733106 Filing: 000095017022001087 The citation records this snapshot. The page link may show a newer release later.	USD 67.26 million Calculation and evidence 89527000 − 22269000 USD Exact free cash flow: 67258000 USD 2019-01-01 – 2019-12-31: 89527000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 22269000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2019-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 67258000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 89527000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017022001087/clb-20211231.htm#2590878 Filing: 000095017022001087 Input fundies:CapitalExpenditure: 22269000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017022001087/clb-20211231.htm#4733106 Filing: 000095017022001087 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 97.64 million Exact value Exact value: -97637000 USD 2020-01-01 – 2020-12-31: -97637000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2020-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: -97637000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -97637000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2232677 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.	USD 57.87 million Exact value Exact value: 57868000 USD 2020-01-01 – 2020-12-31: 57868000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2020-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 57868000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 57868000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2998629 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.	USD 11.88 million Exact value Exact value: 11880000 USD 2020-01-01 – 2020-12-31: 11880000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2020-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 11880000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11880000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5175908 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.	USD 45.99 million Calculation and evidence 57868000 − 11880000 USD Exact free cash flow: 45988000 USD 2020-01-01 – 2020-12-31: 57868000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 11880000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2020-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 45988000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 57868000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2998629 Filing: 000095017023002412 Input fundies:CapitalExpenditure: 11880000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5175908 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 19.73 million Exact value Exact value: 19727000 USD 2021-01-01 – 2021-12-31: 19727000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2021-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: 19727000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 19727000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2230335 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.	USD 36.58 million Exact value Exact value: 36579000 USD 2021-01-01 – 2021-12-31: 36579000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2021-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 36579000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 36579000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2996571 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.	USD 13.54 million Exact value Exact value: 13539000 USD 2021-01-01 – 2021-12-31: 13539000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2021-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 13539000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13539000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5114241 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.	USD 23.04 million Calculation and evidence 36579000 − 13539000 USD Exact free cash flow: 23040000 USD 2021-01-01 – 2021-12-31: 36579000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 13539000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2021-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 23040000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 36579000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2996571 Filing: 000095017023002412 Input fundies:CapitalExpenditure: 13539000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5114241 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 19.45 million Exact value Exact value: 19453000 USD 2022-01-01 – 2022-12-31: 19453000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CORE LABORATORIES N V · 2022-12-31 CORE LABORATORIES N V (edgar:1000229) Net Income: 19453000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 19453000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2228193 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.	USD 24.96 million Exact value Exact value: 24956000 USD 2022-01-01 – 2022-12-31: 24956000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CORE LABORATORIES N V · 2022-12-31 CORE LABORATORIES N V (edgar:1000229) Operating Cash Flow: 24956000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 24956000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2994513 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.	USD 10.22 million Exact value Exact value: 10216000 USD 2022-01-01 – 2022-12-31: 10216000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CORE LABORATORIES N V · 2022-12-31 CORE LABORATORIES N V (edgar:1000229) Capital Expenditure: 10216000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10216000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5052966 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.	USD 14.74 million Calculation and evidence 24956000 − 10216000 USD Exact free cash flow: 14740000 USD 2022-01-01 – 2022-12-31: 24956000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 10216000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CORE LABORATORIES N V · 2022-12-31 CORE LABORATORIES N V (edgar:1000229) Free cash flow: 14740000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T19:13:22Z Snapshot: b86bc6b8091b2f19e2d2d567ad717802f60750ec593aad4fbba9a8701c038965 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 24956000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#2994513 Filing: 000095017023002412 Input fundies:CapitalExpenditure: 10216000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000229/000095017023002412/clb-20221231.htm#5052966 Filing: 000095017023002412 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

122 filings · 6,913 latest values · 6,686 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001000229, 1000229, CLB, edgar:1000229

Also known as CORE LABORATORIES N V, CORE LABORATORIES N.V.

CORE LABORATORIES N V

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation